Crow Point Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-12,744
Closed -$1.64M 106
2019
Q3
$1.64M Buy
+12,744
New +$1.68M 0.24% 56
2017
Q3
Sell
-810
Closed -$107K 260
2017
Q2
$107K Sell
810
-368
-31% -$46.9K 0.02% 151
2017
Q1
$147K Buy
1,178
+317
+37% +$37.9K 0.02% 150
2016
Q4
$99K Sell
861
-1,953
-69% -$226K 0.02% 156
2016
Q3
$330K Buy
+2,814
New +$341K 0.05% 98
2015
Q3
$348K Sell
3,728
-60
-2% -$5.8K 0.05% 144
2015
Q2
$369K Buy
3,788
+100
+3% +$10K 0.05% 151
2015
Q1
$371K Buy
+3,688
New +$375K 0.05% 145
2014
Q3
$483K Buy
+4,530
New +$470K 0.06% 127

Other funds holding JNJ

Crow Point Partners's JNJ Position: Q4 2019 in Review

Crow Point Partners sold out of Johnson & Johnson (JNJ) in Q4 2019, closing a stake of 12,744 shares — an estimated $1.64M sold.

Crow Point Partners first reported a position in JNJ in Q3 2014 and held it in 9 quarters. The position peaked at $1.64M in Q3 2019. 2,990 funds tracked by Wall St. Rank hold JNJ as of Q4 2019.

  • Crow Point Partners reported no remaining Johnson & Johnson position as of Q4 2019 after selling out during the quarter.
  • Crow Point Partners sold 12,744 Johnson & Johnson shares in Q4 2019, an estimated $1.64M.
  • Crow Point Partners first reported a position in Johnson & Johnson in Q3 2014 and held it in 9 quarters.
  • Crow Point Partners's Johnson & Johnson position peaked at $1.64M in Q3 2019.
  • 2,990 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2019.

Based on Crow Point Partners's 13F filing for Q4 2019, filed 14 Feb 2020.